newsfilter
← Latest News
GlobeNewswire·

Ambrx to Present at Multiple Upcoming Investor Meetings

SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (or the "Company") (NASDAQ:AMAM), today announced that Daniel J. O'Connor, Chief Executive Officer and President of Ambrx, will present a